Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Potent and selective inhibitors of NAV1.7

Potent and selective inhibitors of NAV1.7

US Patent 9636418 · Granted May 2, 2017

Estimated economic value: $573,828,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating or ameliorating metabolic disorders using antagonistic bindin2025
KRAS G12C inhibitors and methods of using the same2025
Substituted pyridine derivatives as SARM1 inhibitors2025
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agon2025
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agon2025
Method of treating or ameliorating metabolic disorders using GLP-1 receptor agon2025
Substituted pyridine derivatives as SARM1 inhibitors2024
Substituted pyridine derivatives as SARM1 inhibitors2024
Substituted pyridine derivatives as SARM1 inhibitors2024
HTT modulators for treating Huntington's disease2023
Apelin polypeptides2023
Apelin polypeptides2023